Search

We aim to discover and develop safer and more effective treatments by doing inventive and rigorous research to improve outcomes for kids with cancer.

The Translational Genomics in Leukaemia team is focused on identifying the causes of leukaemia, with the goal of developing new targeted treatments to improve quality of care and long-term survival for all children with leukaemia.

Our Child Health Analytics Team uses cutting-edge technologies to better understand how and why the health and wellbeing of children varies from place to place. We develop innovative geospatial methods that can harness large, complex datasets to pinpoint hotspots of elevated risk, evaluate change through time, and explore underlying drivers.

The Geospatial and Tuberculosis (GeoTB) team led by Kefyalew Alene focuses on designing an innovative approach for improving the efficiency and effectiveness of public health interventions to help control and ultimately eliminate tuberculosis in high-burden countries.

The Global Disease Modelling group informs development and implementation of drugs, medical treatments and non-medical interventions to effectively tackle disease. They build mathematical models of diseases, designed to take into account the complex constellation of interactions between pathogens, humans, diseases, the environment and entire healthcare systems.

What a fabulous day we had on Sunday at the HBF Run for a Reason in Perth, where Rett syndrome was extremely well represented!

Following last year's World Rett Syndrome Congress held in New Orleans, the 3rd European Rett Syndrome Conference was held in the Netherlands over 3 days.

On Sunday May 25th, the 'I love someone with Rett syndrome' team participated in the annual HBF Run for a Reason.

You can't stop loving them: the gift of a grandchild can sometimes be painful, writes Wendy Macklin.

Our InterRett team visited Geelong, Australia to attend the first ever Rett Syndrome Association of Australia national conference.